These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6820764)

  • 41. [A study on microbiological characteristics and sensitivity to antibiotics of 108 "Pseudomonas aeruginosa" strains collected during hospital infections (author's transl)].
    De Vito DD
    Ann Sclavo; 1979; 21(4):425-34. PubMed ID: 122052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First clonal spread of KPC-producing Pseudomonas aeruginosa in Buenos Aires, Argentina.
    Santella G; Cittadini R; Papalia M; Vera Ocampo C; Del Castillo M; Vay C; Gutkind G; Radice M
    Infect Genet Evol; 2012 Dec; 12(8):2003-5. PubMed ID: 22484108
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro activity of azithromycin as an antipseudomonal agent.
    Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
    [No Abstract]   [Full Text] [Related]  

  • 45. Pyocine types and antibiotic sensitivity of hospital strains of Pseudomonas aeruginosa.
    Shrinivas ; Bhatia VN; Ramachandran K
    Indian J Pathol Bacteriol; 1971 Jan; 14(1):24-31. PubMed ID: 5004283
    [No Abstract]   [Full Text] [Related]  

  • 46. [The "in vitro" susceptibility of pseudomonas aeruginosa to tobramycin (author's transl)].
    Fernández H; Otth L
    Rev Med Chil; 1976 Jul; 104(7):473-4. PubMed ID: 828757
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antibiograms of Pseudomonas aeruginosa].
    Delmotte A; Beumer J; Cotton E; Dekeyser-Delmotte N; Meitert E; Meitert S; Millet M; Theodorovici G; Vanden Abbeele KG; Yourassowsky E
    Acta Clin Belg Suppl; 1971; 7():57-64. PubMed ID: 5004795
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sensitivity to antibiotics of Pseudomonas aeruginosa isolated from patients in the years 1986-1988].
    Gościniak G; Dolna I; Ruczkowska J; Fleischer M
    Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1028-32. PubMed ID: 2517806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [In-vitro antibiotic resistance of hospital and non-hospital strains of Pseudomonas aeruginosa].
    Ceddia T; Marinucci MC; Parravano N
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):529-33. PubMed ID: 121701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Bacteriological study on specimens from the Department of Critical Care Medicine (DCCM), Nippon Medical School. II. Serotype and drug-sensitivity of Pseudomonas aeruginosa].
    Satsuta K; Kurokawa A; Ootsuka T
    Kansenshogaku Zasshi; 1983 Mar; 57(3):195-204. PubMed ID: 6413598
    [No Abstract]   [Full Text] [Related]  

  • 51. Pseudomonas aeruginosa: comparative study of aeruginocin typing and antibiotic susceptibility patterns.
    Agrawal SK; Tewari L
    Indian J Med Sci; 1981 Dec; 35(12):281-4. PubMed ID: 6813256
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimicrobial susceptibility of mucoid Pseudomonas aeruginosa and their spontaneously occurring non-mucoid derivatives.
    Markowitz SM; Macrina FL; Phibbs PV
    J Antimicrob Chemother; 1980 Mar; 6(2):251-60. PubMed ID: 6769896
    [No Abstract]   [Full Text] [Related]  

  • 53. [Bacteriological study on specimens from the Department of Critical Care Medicine (DCCM), Nippon Medical School. I. Serotype and drug-sensitivity of Pseudomonas aeruginosa (author's transl)].
    Kobayashi Y; Sastuta K; Kurokawa A; Oostuka T
    Kansenshogaku Zasshi; 1981 Apr; 55(4):242-53. PubMed ID: 6793674
    [No Abstract]   [Full Text] [Related]  

  • 54. [Susceptibility of Pseudomonas aeruginosa in relation to the methods of investigation].
    Babić I; Skalova R; Hajsig D; Sik T; Radosević A; Frisić D; Vadnjal A; Zvokelj-Krizan B
    Vojnosanit Pregl; 1978 Oct; 35(5):338-40. PubMed ID: 103321
    [No Abstract]   [Full Text] [Related]  

  • 55. [Melanin-forming cultures of Pseudomonas aeruginosa].
    Rozhavin MA; Tydel'skaia IL
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):21-3. PubMed ID: 116457
    [No Abstract]   [Full Text] [Related]  

  • 56. PME-1-producing Pseudomonas aeruginosa in Qatar.
    Zowawi HM; Ibrahim E; Syrmis MW; Wailan AM; AbdulWahab A; Paterson DL
    Antimicrob Agents Chemother; 2015; 59(6):3692-3. PubMed ID: 25870054
    [No Abstract]   [Full Text] [Related]  

  • 57. Serotyping of Pseudomonas aeruginosa.
    Young VM; Moody MR
    J Infect Dis; 1974 Nov; 130 Suppl(0):S47-52. PubMed ID: 4214463
    [No Abstract]   [Full Text] [Related]  

  • 58. Composite linear models for incomplete multinomial data.
    Baker SG
    Stat Med; 1994 Mar 15-Apr 15; 13(5-7):609-22. PubMed ID: 8023037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serological group differentiation of Pseudomonas aeruginosa from various sources.
    Thörne H; Kyrkjebö A
    Acta Vet Scand; 1966; 7(4):289-95. PubMed ID: 4960200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of Dunphy et al.: Suggestions to Solidify, Clarify, and Focus without Substantial New Work.
    Springer M
    Cell Syst; 2019 Jan; 8(1):1-2. PubMed ID: 30677398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.